ELV vs HUM
Elevance Health (ELV) and Humana (HUM) compared side by side. Elevance Health (ELV) is larger, with a market cap of $95.4B versus $50.7B for Humana, about 1.9 times the size. On trailing earnings, ELV is cheaper at 18.7x versus 39.9x for HUM.
Head to head
| Metric | ELV | HUM |
|---|---|---|
| Market cap | $95.4B | $50.7B |
| P/E (TTM) | 18.7x | 39.9x |
| Forward P/E | 14.6x | 24.7x |
| Revenue (TTM) | $201.8B | $145.7B |
| Revenue growth | 1.4% | 26.2% |
| Gross margin | 26.4% | 13.7% |
| Operating margin | 4.2% | 3.5% |
| Free cash flow | $6.3B | $1.9B |
| Dividend yield | 1.56% | 0.84% |
| 1-year return | +29.6% | +46.5% |
| 5-year return (annual) | +1.8% | -0.8% |
| Max drawdown | -67% | -85% |
| FI Handbook grade | B- | C |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
ELV vs HUM FAQ
Which is bigger, ELV or HUM?
Elevance Health (ELV) is larger, with a market cap of $95.4B versus $50.7B for Humana, about 1.9 times the size.
Is ELV or HUM cheaper?
On trailing earnings, ELV is cheaper at 18.7x versus 39.9x for HUM. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, ELV or HUM?
HUM returned +46.5% over the past year including dividends, versus +29.6% for ELV, through October 23, 2026.
Which pays a higher dividend, ELV or HUM?
ELV yields 1.56% versus 0.84% for HUM.
Full pages: Elevance Health · Humana